Seasonal Variation of Maternally Derived Respiratory Syncytial Virus Antibodies and Association with Infant Hospitalizations for Respiratory Syncytial Virus

Journal of Pediatrics

Volumn 154, Issue 2, 2009, Pages

  Stensballe, Lone Graff ^a,c   Ravn, Henrik ^a,c   Kristensen, Kim ^b   Meakins, Tiffany ^d   Aaby, Peter ^a,c   Simoes, Eric A F ^d  

^a STATENS SERUM INSTITUT   (Denmark)

^b Rigshospitalet   (Denmark)

^c BANDIM HEALTH PROJECT   (Guinea-Bissau)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENMARK; DISEASE ASSOCIATION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEASONAL VARIATION; STATISTICAL ANALYSIS; UMBILICAL CORD BLOOD;

EID: 58249123481     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.07.053     Document Type: Article

References (10)

1. Roca A., Abacassamo F., Loscertales M.P., Quinto L., Gomez-Olive X., Fenwick F., et al. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique. J Med Virol 67 (2002) 616-623
2. de Sierra T.M., Kumar M.L., Wasser T.E., Murphy B.R., and Subbarao E.K. Respiratory syncytial virus-specific immunoglobulins in preterm infants. J Pediatr 122 (1993) 787-791
3. Connors. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 102 (1998) 531-537
4. Hall C.B., Walsh E.E., Schnabel K.C., Long C.E., McConnochie K.M., Hildreth S.W., et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 162 (1990) 1283-1290
5. Eriksson M., Bennet R., Rotzen-Ostlund M., von Sydow M., and Wirgart B.Z. Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr 91 (2002) 593-598
6. Stensballe L.G., Devasundaram J.K., and Simoes E.A. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J 22 (2003) S21-S32
7. Olsen J., Melbye M., Olsen S.F., Sorensen T.I., Aaby P., Andersen A.M., et al. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health 29 (2001) 300-307
8. Stensballe L.G., Kristensen K., Nielsen J., and Aaby P. Diagnosis coding in The Danish National Patient Registry for respiratory syncytial virus infections. Scand J Infect Dis 37 (2005) 747-752
9. Anderson L.J., Hierholzer J.C., Bingham P.G., and Stone Y.O. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J Clin Microbiol 22 (1985) 1050-1052
10. Piedra P.A., Jewell A.M., Cron S.G., Atmar R.L., and Glezen W.P. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine 21 (2003) 3479-3482